Navidea Biopharmaceuticals Inc (NAVB)
0.0376
0.00 (0.00%)
USD |
OTCM |
Apr 25, 15:02
Navidea Biopharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2022 | -0.2863 |
| September 30, 2022 | -0.3611 |
| June 30, 2022 | -0.1589 |
| March 31, 2022 | -0.0475 |
| December 31, 2021 | -4.255 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.0445 |
| December 31, 2020 | 0.5666 |
| September 30, 2020 | 2.154 |
| June 30, 2020 | -0.1743 |
| March 31, 2020 | -0.0965 |
| December 31, 2019 | -0.1898 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.0354 |
| March 31, 2019 | -0.3465 |
| December 31, 2018 | 0.1814 |
| September 30, 2018 | 1.613 |
| June 30, 2018 | 1.039 |
| March 31, 2018 | 0.5319 |
| December 31, 2017 | 0.2068 |
| September 30, 2017 | 0.1291 |
| June 30, 2017 | 0.1198 |
| March 31, 2017 | 0.0969 |
| December 31, 2016 | -0.9041 |
| Date | Value |
|---|---|
| September 30, 2016 | -0.9682 |
| June 30, 2016 | -0.9502 |
| March 31, 2016 | -1.056 |
| December 31, 2015 | -1.125 |
| September 30, 2015 | -1.172 |
| June 30, 2015 | -1.312 |
| March 31, 2015 | -0.9875 |
| December 31, 2014 | -1.135 |
| September 30, 2014 | -1.039 |
| June 30, 2014 | -1.310 |
| March 31, 2014 | -2.118 |
| December 31, 2013 | -6.900 |
| September 30, 2013 | 3.134 |
| June 30, 2013 | -14.90 |
| March 31, 2013 | -4.784 |
| December 31, 2012 | -6.893 |
| September 30, 2012 | 2.186 |
| June 30, 2012 | 0.6621 |
| March 31, 2012 | 0.4426 |
| December 31, 2011 | 0.3055 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.0015 |
| March 31, 2011 | 0.0042 |
| December 31, 2010 | 0.0151 |
| September 30, 2010 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-4.255
Minimum
Dec 2021
2.154
Maximum
Sep 2020
-0.1846
Average
-0.0475
Median
Mar 2022
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | 0.0229 |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.4243 |
| Asensus Surgical Inc | 0.00 |
| Senseonics Holdings Inc | 1.151 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 5.699M |
| Total Liabilities (Quarterly) | 8.679M |
| Shareholders Equity (Quarterly) | -3.273M |